Richmond, CA, August 13, 2018 – FlemingMartin is pleased to announce that the worldwide pioneer in the field of robotic exoskeletons, Ekso Bionics (NASDAQ: EKSO), has hired John “Jack” Glenn as their new Chief Financial Officer.

Mr. Glenn brings over 25 years of expertise as a senior finance executive across the Medical Device, Diagnostics, and Biopharmaceutical industries. Mr. Glenn has a proven track record of growing enterprise value at both public and private companies, managing numerous debt and equity financings, and guiding global expansion. Mr. Glenn has played an instrumental role in steering multiple acquisitions and successful exits (Invivo, Cholestech, Solta Medical) over his stellar career. Mr. Glenn received his MBA from Santa Clara University and his BSBA from the University of Nevada, Reno.

 

Ekso Bionics (NASDAQ: EKSO) develops technology to enhance human mobility, strength, and endurance. The Company has commercialized wearable exoskeletons and robotic-assist devices for a variety of medical and industrial applications.

 

 

FlemingMartin is a leading retained executive search firm with offices in Northern and Southern California. FlemingMartin partners with Boards, Private Equity Firms, and CEOs of companies to build successful execution-focused management teams. The Firm’s principals are trusted advisors and business partners who enable companies to gain powerful, far-reaching, and lasting contributions from their executive-level human capital.